Published in J Biol Chem on April 14, 2003
Some assembly required: yeast septins provide the instruction manual. Trends Cell Biol (2005) 1.96
What causes cell death in Parkinson's disease? Ann Neurol (2008) 1.66
Here come the septins: novel polymers that coordinate intracellular functions and organization. J Cell Sci (2006) 1.60
The septins. Genome Biol (2003) 1.58
Molecular mechanisms of alpha-synuclein neurodegeneration. Biochim Biophys Acta (2008) 1.51
Forchlorfenuron alters mammalian septin assembly, organization, and dynamics. J Biol Chem (2008) 1.43
Conquering the complex world of human septins: implications for health and disease. Clin Genet (2010) 1.29
Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease. Proc Natl Acad Sci U S A (2004) 1.29
Septins enforce morphogenetic events during sexual reproduction and contribute to virulence of Cryptococcus neoformans. Mol Microbiol (2009) 1.25
The role of DYRK1A in neurodegenerative diseases. FEBS J (2010) 1.23
Septins regulate developmental switching from microdomain to nanodomain coupling of Ca(2+) influx to neurotransmitter release at a central synapse. Neuron (2010) 1.22
Regulation of distinct septin rings in a single cell by Elm1p and Gin4p kinases. Mol Biol Cell (2009) 1.13
Septin functions in organ system physiology and pathology. Biol Chem (2014) 1.10
A draft of the human septin interactome. PLoS One (2010) 1.06
Mitochondrial dysfunction precedes neurodegeneration in mahogunin (Mgrn1) mutant mice. Neurobiol Aging (2007) 0.94
The role of the Parkinson's disease gene PARK9 in essential cellular pathways and the manganese homeostasis network in yeast. PLoS One (2012) 0.93
Phosphorylation of septin 3 on Ser-91 by cGMP-dependent protein kinase-I in nerve terminals. Biochem J (2004) 0.89
Parkin promotes degradation of the mitochondrial pro-apoptotic ARTS protein. PLoS One (2012) 0.85
Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndrome. J Neuropathol Exp Neurol (2011) 0.85
Aberrant septin 11 is associated with sporadic frontotemporal lobar degeneration. Mol Neurodegener (2011) 0.84
Synaptic dysfunction and septin protein family members in neurodegenerative diseases. Mol Neurodegener (2015) 0.82
Bioactive marine drugs and marine biomaterials for brain diseases. Mar Drugs (2014) 0.81
Defining the limits: Protein aggregation and toxicity in vivo. Crit Rev Biochem Mol Biol (2014) 0.81
HSP70 and constitutively active HSF1 mediate protection against CDCrel-1-mediated toxicity. Mol Ther (2008) 0.79
Chronic overload of SEPT4, a parkin substrate that aggregates in Parkinson's disease, causes behavioral alterations but not neurodegeneration in mice. Mol Brain (2013) 0.78
Septin expression in proliferative retinal membranes. J Histochem Cytochem (2007) 0.78
Septin/anillin filaments scaffold central nervous system myelin to accelerate nerve conduction. Elife (2016) 0.75
Structural and Thermodynamic Properties of Septin 3 Investigated by Small-Angle X-Ray Scattering. Biophys J (2015) 0.75
Performance Metrics for Selecting Single Nucleotide Polymorphisms in Late-onset Alzheimer's Disease. Sci Rep (2016) 0.75
The Mammalian Septin Interactome. Front Cell Dev Biol (2017) 0.75
Functional genomics reveals genes involved in protein secretion and Golgi organization. Nature (2006) 3.72
Entrapment of intracytosolic bacteria by septin cage-like structures. Cell Host Microbe (2010) 3.39
Role of Septin cytoskeleton in spine morphogenesis and dendrite development in neurons. Curr Biol (2007) 2.60
A mitotic septin scaffold required for Mammalian chromosome congression and segregation. Science (2005) 2.37
Functional connectivity in the human language system: a cortico-cortical evoked potential study. Brain (2004) 2.35
White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke (2004) 2.29
Cortical organization by the septin cytoskeleton is essential for structural and mechanical integrity of mammalian spermatozoa. Dev Cell (2005) 2.21
Chronic kidney disease, 24-h blood pressure and small vessel diseases are independently associated with cognitive impairment in lacunar infarct patients. Hypertens Res (2011) 2.15
Sept4, a component of presynaptic scaffold and Lewy bodies, is required for the suppression of alpha-synuclein neurotoxicity. Neuron (2007) 2.08
Amoeboid T lymphocytes require the septin cytoskeleton for cortical integrity and persistent motility. Nat Cell Biol (2008) 1.88
Rb Regulates DNA damage response and cellular senescence through E2F-dependent suppression of N-ras isoprenylation. Cancer Cell (2009) 1.80
Nationwide survey of juvenile muscular atrophy of distal upper extremity (Hirayama disease) in Japan. Amyotroph Lateral Scler (2006) 1.73
Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb (2007) 1.70
Epithelial polarity requires septin coupling of vesicle transport to polyglutamylated microtubules. J Cell Biol (2008) 1.65
Subthreshold low-frequency repetitive transcranial magnetic stimulation over the premotor cortex modulates writer's cramp. Brain (2004) 1.59
Impact of early surgery in the active phase on long-term outcomes in left-sided native valve infective endocarditis. J Thorac Cardiovasc Surg (2011) 1.48
Pathophysiology of unilateral asterixis due to thalamic lesion. Clin Neurophysiol (2012) 1.48
Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model. Neurobiol Aging (2013) 1.46
Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb (2007) 1.45
Clinical outcomes of medical therapy and timely operation in initially diagnosed type a aortic intramural hematoma: a 20-year experience. Circulation (2009) 1.43
Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial. Stem Cells (2009) 1.43
Hypersomnia caused by isolated angiitis of the CNS. Intern Med (2005) 1.42
Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version. J Atheroscler Thromb (2013) 1.42
Amyotrophic lateral sclerosis with IgM antibody against gangliosides GM2 and GD2. Intern Med (2003) 1.41
Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease. Neuroimage (2006) 1.40
[A case of status epilepticus with a possible therapeutic effect by dantrolene sodium]. Rinsho Shinkeigaku (2011) 1.40
Successful thrombus aspiration during primary percutaneous coronary intervention reduces infarct size and preserves myocardial viability: a cardiac magnetic resonance imaging study. J Invasive Cardiol (2011) 1.39
Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts. Acta Neuropathol (2011) 1.34
The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer. Clin Cancer Res (2004) 1.34
Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion. Stroke (2007) 1.34
Characteristics of intracranial branch atheromatous disease and its association with progressive motor deficits. J Neurol Sci (2011) 1.30
Functional connectivity in human cortical motor system: a cortico-cortical evoked potential study. Brain (2006) 1.28
The neural basis of executive function in working memory: an fMRI study based on individual differences. Neuroimage (2004) 1.27
Tissue inhibitors of metalloproteinase 2 inhibits endothelial cell migration through increased expression of RECK. Cancer Res (2004) 1.27
Isolation of hyperactive mutants of mammalian target of rapamycin. J Biol Chem (2008) 1.26
RECK modulates Notch signaling during cortical neurogenesis by regulating ADAM10 activity. Nat Neurosci (2007) 1.26
Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents. Stroke (2006) 1.26
RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling. Cancer Metastasis Rev (2003) 1.25
Annular geometry in patients with chronic ischemic mitral regurgitation: three-dimensional magnetic resonance imaging study. Circulation (2005) 1.25
RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis. Clin Cancer Res (2003) 1.25
The neural basis of individual differences in working memory capacity: an fMRI study. Neuroimage (2003) 1.23
The role of rostral Brodmann area 6 in mental-operation tasks: an integrative neuroimaging approach. Cereb Cortex (2002) 1.22
Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Brain Res (2002) 1.21
Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice. Oncogene (2004) 1.19
Temporal activation pattern of parietal and premotor areas related to praxis movements. Clin Neurophysiol (2005) 1.18
Structural insights shed light onto septin assemblies and function. Curr Opin Cell Biol (2008) 1.17
Rho and anillin-dependent control of mDia2 localization and function in cytokinesis. Mol Biol Cell (2010) 1.17
Mammalian septins nomenclature. Mol Biol Cell (2002) 1.16
Functional roles of the cingulo-frontal network in performance on working memory. Neuroimage (2004) 1.16
Successful closure of a patent ductus arteriosus using an aortic stent graft. Ann Thorac Cardiovasc Surg (2011) 1.15
Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer. Eur J Cancer (2004) 1.15
Proteomic pattern analysis discriminates among multiple sclerosis-related disorders. Ann Neurol (2012) 1.14
Chronic cerebral hypoperfusion accelerates amyloid beta deposition in APPSwInd transgenic mice. Brain Res (2009) 1.13
14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains. J Neuropathol Exp Neurol (2002) 1.11
Cortical microinfarcts in Alzheimer's disease and subcortical vascular dementia. Neuroreport (2009) 1.11
A mouse model characterizing features of vascular dementia with hippocampal atrophy. Stroke (2010) 1.11
Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate. Blood (2005) 1.10
Septins as diagnostic markers for a subset of human asthenozoospermia. J Urol (2008) 1.09
Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia/reperfusion injury in a rat model. Lab Invest (2003) 1.09
Transcriptional control of the RECK metastasis/angiogenesis suppressor gene. Cancer Detect Prev (2002) 1.08
Patient health literacy and patient-physician information exchange during a visit. Fam Pract (2009) 1.08
Nardilysin regulates axonal maturation and myelination in the central and peripheral nervous system. Nat Neurosci (2009) 1.08
Neural correlates underlying mental calculation in abacus experts: a functional magnetic resonance imaging study. Neuroimage (2003) 1.08
Disruption of Sept6, a fusion partner gene of MLL, does not affect ontogeny, leukemogenesis induced by MLL-SEPT6, or phenotype induced by the loss of Sept4. Mol Cell Biol (2005) 1.07
Metabolic syndrome. J Atheroscler Thromb (2008) 1.06
Phosphatidic acid (PA)-preferring phospholipase A1 regulates mitochondrial dynamics. J Biol Chem (2014) 1.05
Retracted Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice. J Clin Invest (2010) 1.05
Selective white matter abnormalities in a novel rat model of vascular dementia. Neurobiol Aging (2011) 1.05
"Burst and slow complexes" in nonconvulsive epileptic status. Epileptic Disord (2006) 1.05
Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes alpha-synuclein inclusions. J Biol Chem (2003) 1.04
Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors. J Biol Chem (2010) 1.04
Plasmalogens in human serum positively correlate with high- density lipoprotein and decrease with aging. J Atheroscler Thromb (2007) 1.03
Apoptosis signal-regulating kinase 1 is a novel target molecule for cognitive impairment induced by chronic cerebral hypoperfusion. Arterioscler Thromb Vasc Biol (2013) 1.03
Rb and N-ras function together to control differentiation in the mouse. Mol Cell Biol (2003) 1.03
Nras loss induces metastatic conversion of Rb1-deficient neuroendocrine thyroid tumor. Nat Genet (2005) 1.03
Aggressive surgical and chemotherapeutic treatment of advanced pancreatoblastoma associated with tumor thrombus in portal vein. J Pediatr Surg (2006) 1.02
The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) interacts with membrane type 1 matrix metalloproteinase and CD13/aminopeptidase N and modulates their endocytic pathways. J Biol Chem (2007) 1.01
Painful neck on rotation: diagnostic significance for crowned dens syndrome. J Neurol (2010) 1.01
Commensal bacteria-dependent indole production enhances epithelial barrier function in the colon. PLoS One (2013) 1.00
Upregulation of ceramide and its regulating mechanism in a rat model of chronic cerebral ischemia. Brain Res (2004) 1.00
Submembranous septins as relatively stable components of actin-based membrane skeleton. Cytoskeleton (Hoboken) (2011) 0.99
A comparative study on the expression of cyclooxygenase and 5-lipoxygenase during cerebral ischemia in humans. Acta Neuropathol (2002) 0.99
Spatiotemporal association of DNAJB13 with the annulus during mouse sperm flagellum development. BMC Dev Biol (2009) 0.99
Evidence for a wide distribution of negative motor areas in the perirolandic cortex. Clin Neurophysiol (2005) 0.99
Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK. J Mol Cell Cardiol (2013) 0.98
Negative motor seizure arising from the negative motor area: is it ictal apraxia? Epilepsia (2009) 0.98